BE732141A - - Google Patents

Info

Publication number
BE732141A
BE732141A BE732141A BE732141A BE732141A BE 732141 A BE732141 A BE 732141A BE 732141 A BE732141 A BE 732141A BE 732141 A BE732141 A BE 732141A BE 732141 A BE732141 A BE 732141A
Authority
BE
Belgium
Application number
BE732141A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE732141A publication Critical patent/BE732141A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE732141A 1969-04-24 1969-04-25 BE732141A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21084/69A GB1254057A (en) 1969-04-24 1969-04-24 Improvements in or relating to therapeutical composition containing vincamine

Publications (1)

Publication Number Publication Date
BE732141A true BE732141A (enrdf_load_stackoverflow) 1969-10-01

Family

ID=10156932

Family Applications (1)

Application Number Title Priority Date Filing Date
BE732141A BE732141A (enrdf_load_stackoverflow) 1969-04-24 1969-04-25

Country Status (2)

Country Link
BE (1) BE732141A (enrdf_load_stackoverflow)
GB (1) GB1254057A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392717A1 (en) * 1989-04-04 1990-10-17 Eli Lilly And Company Pharmaceutical formulations containing immunoglobulin conjugates

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392717A1 (en) * 1989-04-04 1990-10-17 Eli Lilly And Company Pharmaceutical formulations containing immunoglobulin conjugates

Also Published As

Publication number Publication date
GB1254057A (en) 1971-11-17

Similar Documents

Publication Publication Date Title
AU2270770A (enrdf_load_stackoverflow)
AU465452B2 (enrdf_load_stackoverflow)
AU429630B2 (enrdf_load_stackoverflow)
AU450150B2 (enrdf_load_stackoverflow)
AU442375B2 (enrdf_load_stackoverflow)
AU2355770A (enrdf_load_stackoverflow)
AU470301B1 (enrdf_load_stackoverflow)
AU5113869A (enrdf_load_stackoverflow)
AU442535B2 (enrdf_load_stackoverflow)
AU410358B2 (enrdf_load_stackoverflow)
AU428131B2 (enrdf_load_stackoverflow)
AU428074B2 (enrdf_load_stackoverflow)
AU428129B2 (enrdf_load_stackoverflow)
AU438128B2 (enrdf_load_stackoverflow)
AU417208B2 (enrdf_load_stackoverflow)
AU442285B2 (enrdf_load_stackoverflow)
AU442322B2 (enrdf_load_stackoverflow)
AU442357B2 (enrdf_load_stackoverflow)
AU425297B2 (enrdf_load_stackoverflow)
AU442380B2 (enrdf_load_stackoverflow)
AU442463B2 (enrdf_load_stackoverflow)
AU442554B2 (enrdf_load_stackoverflow)
AU442538B2 (enrdf_load_stackoverflow)
AU5228269A (enrdf_load_stackoverflow)
AU4540468A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MESDAMES OLIVIER LOUISETTE & ALBERT ODILE

Effective date: 19890425